BioLife Solutions Ownership | Who Owns BioLife Solutions?


OverviewForecastRevenueFinancialsChartTranscripts

BioLife Solutions Ownership Summary


BioLife Solutions is owned by 22.67% institutional investors, 2.39% insiders, and 74.94% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 13.62% of BLFS shares. T. Rowe Price Small-Cap Stock is the top mutual fund, with 5.11% of its assets in BioLife Solutions shares.

BLFS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioLife Solutions22.67%2.39%74.94%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryMedical Instruments & Supplies Stocks39.33%13.82%46.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
T. rowe price investment management6.51M13.62%$124.14M
Blackrock funding, inc. /de6.38M13.16%$180.05M
Casdin capital5.96M12.47%$113.66M
Blackrock5.49M12.08%$117.61M
Vanguard group3.09M6.44%$74.65M
Invesco2.35M4.92%$44.81M
State street1.66M3.42%$46.77M
Fmr1.47M3.08%$28.05M
Fred alger management1.08M2.26%$20.61M
Geode capital management1.09M2.24%$30.70M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Casdin capital5.96M8.61%$113.66M
Gagnon advisors274.22K5.12%$7.74M
Roubaix capital309.62K3.13%$8.74M
Gagnon securities535.91K2.98%$15.13M
Summit creek advisors180.54K1.74%$5.10M
Cramer rosenthal mcglynn632.81K0.89%$12.07M
Penbrook management39.70K0.72%$1.12M
Granahan investment management722.06K0.67%$13.78M
Next century growth investors361.94K0.50%$6.91M
Palisade capital management, lp758.66K0.48%$14.48M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management6.51M0.09%1.33M
Cramer rosenthal mcglynn632.81K0.89%632.81K
Roubaix capital309.62K3.13%309.62K
Vanguard fiduciary trust278.73K0.00%278.73K
Blackrock funding, inc. /de6.38M0.00%273.78K

Top Sellers

HolderShares% AssetsChange
Invesco2.35M0.01%-1.58M
William blair investment management---946.62K
Millennium management388.50K0.00%-756.84K
Capricorn fund managers---378.55K
Park west asset management---344.47K

New Positions

HolderShares% AssetsChangeValue
Roubaix capital309.62K3.13%309.62K$8.74M
Vanguard fiduciary trust278.73K0.00%278.73K$5.32M
Diamond hill capital management153.89K0.03%153.89K$4.35M
Raymond james & associates134.19K0.00%134.19K$2.88M
Hodges capital management73.00K0.14%73.00K$2.06M

Sold Out

HolderChange
Larson financial group-4.00
Mendota financial group-4.00
Massmutual trust co fsb/adv-5.00
Rossby financial, lcc-8.00
Capital performance advisors llp-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202696-48.11%10,825,656-77.88%220.22%47-44.05%28-61.64%
Dec 31, 2025137-28.27%24,239,360-49.80%500.50%60-38.78%51-16.39%
Sep 30, 2025183-1.61%48,180,912-0.93%1000.97%95-13.64%5820.83%
Jun 30, 2025190-1.04%49,819,2833.44%1041.00%11230.23%49-22.22%
Mar 31, 20256-96.70%9,932,413-78.79%210.20%1-98.88%3-94.83%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price Small-Cap Stock2.50M5.11%-65.25K
T. Rowe Price US Small-Cap Core Equity2.50M5.11%-67.08K
iShares Core S&P Small-Cap ETF2.41M4.93%-6.72K
Vanguard Total Stock Mkt Idx Inv1.46M2.99%25.80K
Vanguard Morn Total Stk Mkt Idx Investor1.46M2.99%25.80K
Vanguard US Total Market Shares ETF1.38M2.91%-
T. Rowe Price Instl Small-Cap Stock1.36M2.79%-24.38K
T. Rowe Price U.S. SC Core Eq Tr-D1.19M2.43%-30.18K
iShares Russell 2000 ETF1.07M2.19%-19.01K
Alger Small Cap Focus I1.02M2.09%-

Recent Insider Transactions


DateNameRoleActivityValue
May 19, 2026Casdin Partners Master Fund, L.P.-Sell$6.79M
May 21, 2026Casdin Partners Master Fund, L.P.-Sell$15.40M
May 20, 2026Casdin Partners Master Fund, L.P.-Sell$5.92M
Mar 23, 2026Foster Karen A. Chief Quality and OperationsSell$49.40K
Mar 09, 2026Foster Karen A. Chief Quality and OperationsSell$10.00K

Insider Transactions Trends


DateBuySell
2026 Q2-3
2026 Q1-14
2025 Q4-32
2025 Q3-22
2025 Q2-24

BLFS Ownership FAQ


Who Owns BioLife Solutions?

BioLife Solutions shareholders are primarily institutional investors at 22.67%, followed by 2.39% insiders and 74.94% retail investors. The average institutional ownership in BioLife Solutions's industry, Medical Instruments & Supplies Stocks, is 39.33%, which BioLife Solutions falls below.

Who owns the most shares of BioLife Solutions?

BioLife Solutions’s largest shareholders are T. rowe price investment management (6.51M shares, 13.62%), Blackrock funding, inc. /de (6.38M shares, 13.16%), and Casdin capital (5.96M shares, 12.47%). Together, they hold 39.26% of BioLife Solutions’s total shares outstanding.

Does Blackrock own BioLife Solutions?

Yes, BlackRock owns 12.08% of BioLife Solutions, totaling 5.49M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 117.61M$. In the last quarter, BlackRock increased its holdings by 25.13K shares, a 0.46% change.

Who is BioLife Solutions’s biggest shareholder by percentage of total assets invested?

Casdin capital is BioLife Solutions’s biggest shareholder by percentage of total assets invested, with 8.61% of its assets in 5.96M BioLife Solutions shares, valued at 113.66M$.

Who is the top mutual fund holder of BioLife Solutions shares?

T. Rowe Price Small-Cap Stock is the top mutual fund holder of BioLife Solutions shares, with 5.11% of its total shares outstanding invested in 2.5M BioLife Solutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools